TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT02843945: Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source

Sponsor: CivaTech Oncology · Phase: PHASE1/PHASE2 · Area: ONCOLOGY · Target Enrollment: 80 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$5,851,230

Rescue Site Savings

+$3,848,460

Unlock Full NCT02843945 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT02843945 Rescue Dossier →